Next, we sought to determine whether PRMT3 inhibition could elicit similar effects on tumor progression and T cell infiltration by treating Hepa1-6 tumors with SGC707, a PRMT3-specific inhibitor that was previously shown to be highly effective in delaying tumor progression in human HCC cell line models13. This evidence concerns the gene PRMT3 and hepatocellular carcinoma.